Skip to main content
Premium Trial:

Request an Annual Quote

Decode, Pfizer Collaborate on Sequence Variants for Lupus

NEW YORK (GenomeWeb News) – Decode Genetics today announced a research collaboration with Pfizer targeting sequence variants associated with specific clinical phenotypes related to systemic lupus erythematosis.

During the next 18 months, the firms will analyze the genomes of patients to discover sequence variants that could shed light on drug targets and lead to new drug targets.

Kari Stefansson, founder and CEO of Decode, based in Reykjavik, Iceland, said in a statement that the company's research platform "allows us to understand the genetic basis of disease and modifiers of clinical phenotypes in actual patient populations; by doing so, we can rapidly move from targets to patient stratification and from there to companion diagnostics."

Financial and other terms of the deal were not disclosed.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.